Mabel Lung is a senior member of the firm’s Global Investment Solutions Team.  She leads a team of 15 with responsibilities on multi-asset portfolios, primarily for US private clients.  The Manager Research Team evaluates a large spectrum of investment capabilities and constructs portfolios that make complimentary use of these capabilities for desired investment outcome.  These investment capabilities are mostly external to UBS Global Asset Management’s, but also include selective internal capabilities.  The Managed Accounts Portfolio Solutions Team provides separately managed multi-asset portfolios for US private clients, leveraging the firm’s strength in equities, fixed income and active asset allocation to achieve diversified investment results.

Ms. Lung is a member of the Asset Allocation and Currency Committee, and the Dynamic Alpha Committee.  She joined the firm in 1984, after her graduate study in business administration and has held various positions in finance, treasury, and business planning.  Prior to business school, she was a corporate finance analyst at an investment banking firm.

Mabel Lung
Managing Director

If you are interested in learning more about TIGER 21, please complete the contact form and you will receive a copy of our most recent Asset Allocation Report.